It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Three hospitals in Syria's Damascus governorate that are supported by the international medical humanitarian organization Doctors Without Borders Médecins Sans Frontières (MSF) have reported to MSF that they received approximately 3,600 patients displaying neurotoxic symptoms in less than three hours on the morning of Wednesday, August 21, 2013. Of those patients, 355 reportedly died.
Since 2012, MSF has built a strong and reliable collaboration with medical networks, hospitals and medical points in the Damascus governorate, and has been providing them with drugs, medical equipment and technical support. Due to significant security risks, MSF staff members have not been able to access the facilities.
“Medical staff working in these facilities provided detailed information to MSF doctors regarding large numbers of patients arriving with symptoms including convulsions, excess saliva, pinpoint pupils, blurred vision and respiratory distress,” said Dr. Bart Janssens, MSF director of operations.
Patients were treated using MSF-supplied atropine, a drug used to treat neurotoxic symptoms. MSF is now trying to replenish the facilities’ empty stocks and provide additional medical supplies and guidance.